Literature DB >> 21712670

Adult Leigh disease without failure to thrive.

Ken Sakushima1, Sachiko Tsuji-Akimoto, Masaaki Niino, Shinji Saitoh, Ichiro Yabe, Hidenao Sasaki.   

Abstract

INTRODUCTION: Most Leigh disease (LD) patients die before reaching adulthood, but there are reports of "adult LD." The clinical features of adult LD were quite different from those in infant or childhood cases. Here, we describe a normally developed patient with adult LD, who presented with spastic paraplegia that was followed several years later by acute encephalopathy. We also conducted a systemic literature search on adult LD and integrated its various manifestations to arrive at a diagnostic procedure for adult LD. CASE REPORT: A 26-year-old woman presented with acute encephalopathy after spastic paraplegia. On her first admission, she exhibited bilateral basal ganglia lesion on magnetic resonance images and normal serum lactate levels. On second admission, she had acute encephalopathy with lactic acidosis and bilateral basal ganglia and brainstem lesions. A muscle biopsy revealed cytochrome c oxidase deficiency, and a diagnosis of adult LD was made. Despite treatment in the intensive care unit, she died 9 days after admission.
CONCLUSIONS: A review of the literature describing adult LD revealed that developmental delay, COX deficiency, serum lactate elevation, and basal ganglia lesions occurred less frequently than they did in children with LD. Cranial nerve disturbance, pyramidal signs, and cerebellar dysfunction were the primary symptoms in adult LD. Thus, the many differences between childhood and adult LD may be helpful for diagnosing adult LD.

Entities:  

Mesh:

Year:  2011        PMID: 21712670     DOI: 10.1097/NRL.0b013e318217357a

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  8 in total

1.  Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome.

Authors:  Brian Bennett; Daniel Helbling; Hui Meng; Jason Jarzembowski; Aron M Geurts; Marisa W Friederich; Johan L K Van Hove; Michael W Lawlor; David P Dimmock
Journal:  Free Radic Biol Med       Date:  2016-01-08       Impact factor: 7.376

Review 2.  The neuroimaging of Leigh syndrome: case series and review of the literature.

Authors:  Eliana Bonfante; Mary Kay Koenig; Rahmat B Adejumo; Vinu Perinjelil; Roy F Riascos
Journal:  Pediatr Radiol       Date:  2016-01-06

Review 3.  Mitochondrial disease in childhood: nuclear encoded.

Authors:  Amy C Goldstein; Poonam Bhatia; Jodie M Vento
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

4.  A conditional mouse model of complex II deficiency manifesting as Leigh-like syndrome.

Authors:  Fatimah Al Khazal; Molly Nelson Holte; Brad Bolon; Thomas A White; Nathan LeBrasseur; L James Maher Iii
Journal:  FASEB J       Date:  2019-08-30       Impact factor: 5.834

5.  Adult-onset Leigh's disease: A rare entity.

Authors:  Shaik Afshan Jabeen; G Sandeep; Kandadai Rukmini Mridula; Angamuttu Kanikannan Meena; Rupam Borgohain; Challa Sundaram
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

6.  Head Trauma as a Precipitating Factor for Late-onset Leigh Syndrome: a Case Report.

Authors:  Farzad Ashrafi; Hossein Pakdaman; Mehran Arabahmadi; Behdad Behnam
Journal:  Emerg (Tehran)       Date:  2017-01-14

7.  Clinical Characteristics of Early-Onset and Late-Onset Leigh Syndrome.

Authors:  Chan-Mi Hong; Ji-Hoon Na; Soyoung Park; Young-Mock Lee
Journal:  Front Neurol       Date:  2020-04-15       Impact factor: 4.003

8.  Diagnostic Values of Venous Peak Lactate, Lactate-to-pyruvate Ratio, and Fold Increase in Lactate from Baseline in Aerobic Exercise Tests in Patients with Mitochondrial Diseases.

Authors:  Masanori Kurihara; Yusuke Sugiyama; Masaki Tanaka; Kenichiro Sato; Akihiko Mitsutake; Hiroyuki Ishiura; Akatsuki Kubota; Kaori Sakuishi; Toshihiro Hayashi; Atsushi Iwata; Jun Shimizu; Kei Murayama; Shoji Tsuji; Tatsushi Toda
Journal:  Intern Med       Date:  2021-11-27       Impact factor: 1.282

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.